欧洲放射肿瘤学市场预测至 2031 年 - 区域分析 - 按类型（外束放射治疗和内束放射治疗）和应用（乳腺癌、前列腺癌、肺癌、头颈癌、宫颈癌等）
支持放射肿瘤学发展的举措推动欧洲放射肿瘤学市场
各国政府和组织正在推出利用放射疗法快速有效治疗癌症的任务和计划。2023 年 9 月，国际原子能机构 (IAEA) 宣布了“希望之光”旗舰癌症计划，旨在发展放射治疗基础设施。在美国、德国、英国、法国等发达国家，几乎所有患者都可以接受放射治疗。在中等收入国家，60% 的患者和低收入国家十分之一的患者可以接受放射治疗。 “希望之光癌症关爱全民”致力于在世界各地发展放射治疗服务。自该计划启动以来，各国已收到放射治疗设备和操作设备所需的培训，以便及时诊断和治疗。五大洲都参与了该计划，并为该计划贡献了 4550 万美元（4200 万欧元），私营部门投资了 768,902 美元（710,000 欧元）用于支持。此外，Elekta 等制造商与国际原子能机构签署了合作伙伴关系，通过向世界各地提供放射治疗设备来改善癌症治疗。此外，国际原子能机构开始培训来自不同领域的医疗保健专业人员，其中包括 14 名放射肿瘤学家、13 名医学物理学家、4 名核医学技术员、7 名核医学医生、7 名放射药剂师、16 名放射治疗技术员、7 名肿瘤科护士、4 名医学成像技术员和 7 名放射科医生。因此，预计放射治疗举措的激增将增加其在低收入国家的普及率，同时训练有素的专业人员和放射治疗基础设施的发展将在未来几年推动放射肿瘤学市场的增长。
欧洲放射肿瘤学市场概览
德国拥有先进的医疗保健基础设施，可以使用支持放射治疗程序实施的尖端技术。该国还以高度重视创新和研究而闻名。在德国运营的综合癌症中心提供多学科治疗计划，包括放射治疗、手术、化疗和其他医疗程序。2020 年，瓦里安宣布海德堡德国癌症研究中心 (DKFZ) 订购了自适应智能解决方案，这是该国首个 Ethos 疗法。这种由人工智能驱动的全方位解决方案旨在提高放射治疗的功效、适应性和能力。
欧洲放射肿瘤学市场收入及预测至 2031 年（百万美元）
欧洲放射肿瘤学市场细分
欧洲放射肿瘤学市场分为类型、应用和国家。
根据类型，欧洲放射肿瘤学市场分为外束放射治疗和内束放射治疗。外束放射治疗部分在 2023 年占据了更大的市场份额。
在应用方面，欧洲放射肿瘤学市场分为乳腺癌、前列腺癌、肺癌、头颈癌、宫颈癌等。乳腺癌部分在 2023 年占据了最大的市场份额。
按国家/地区，欧洲放射肿瘤学市场分为德国、英国、法国、西班牙、意大利和欧洲其他地区。 2023 年，德国占据了欧洲放射肿瘤学市场的主导份额。
Varian Medical Systems Inc、Elekta AB、Accuray Incorporated、IBA Worldwide (Ion Beam Applications SA)、Becton Dickinson and Co、Nordion、Mevion Medical Systems、NTP RADIOISOTOPES、Mallinckrodt Plc 和 Curium 是欧洲放射肿瘤学市场的一些领先公司。
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. Europe Radiation Oncology Market - Key Market Dynamics
4.1 Market Drivers:
4.1.1 Increasing Prevalence of Cancer
4.1.2 Initiatives to Support Developments in Radiation Oncology
4.2 Market Restraints
4.2.1 High Cost of Radiotherapy Equipment
4.3 Market Opportunities
4.3.1 Strategic Initiatives in Radiation Oncology
4.4 Future Trends
4.4.1 Technological Advancement in Radiation Oncology
4.5 Impact of Drivers and Restraints:
5. Radiation Oncology Market - Europe Market Analysis
5.1 Radiation Oncology Market Revenue (US$ Million), 2021-2031
6. Europe Radiation Oncology Market Analysis - by Types
6.1 External Beam Radiation Therapy
6.1.1 Overview
6.1.2 External Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
6.2 Internal Beam Radiation Therapy
6.2.1 Overview
6.2.2 Internal Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
7. Europe Radiation Oncology Market Analysis - by Application
7.1 Breast Cancer
7.1.1 Overview
7.1.2 Breast Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Prostate Cancer
7.2.1 Overview
7.2.2 Prostate Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Lung Cancer
7.3.1 Overview
7.3.2 Lung Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
7.4 Head and Neck Cancer
7.4.1 Overview
7.4.2 Head and Neck Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
7.5 Cervical Cancer
7.5.1 Overview
7.5.2 Cervical Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8. Europe Radiation Oncology Market - Country Analysis
8.1 Europe
8.1.1 Europe: Radiation Oncology Market - Revenue and Forecast Analysis - by Country
8.1.1.1 Germany: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8.1.1.1.1 Germany: Radiation Oncology Market Breakdown, by Types
8.1.1.1.2 Germany: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
8.1.1.1.3 Germany: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
8.1.1.1.4 Germany: Radiation Oncology Market Breakdown, by Application
8.1.1.2 United Kingdom: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8.1.1.2.1 United Kingdom: Radiation Oncology Market Breakdown, by Types
8.1.1.2.2 United Kingdom: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
8.1.1.2.3 United Kingdom: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
8.1.1.2.4 United Kingdom: Radiation Oncology Market Breakdown, by Application
8.1.1.3 France: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8.1.1.3.1 France: Radiation Oncology Market Breakdown, by Types
8.1.1.3.2 France: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
8.1.1.3.3 France: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
8.1.1.3.4 France: Radiation Oncology Market Breakdown, by Application
8.1.1.4 Spain: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8.1.1.4.1 Spain: Radiation Oncology Market Breakdown, by Types
8.1.1.4.2 Spain: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
8.1.1.4.3 Spain: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
8.1.1.4.4 Spain: Radiation Oncology Market Breakdown, by Application
8.1.1.5 Italy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8.1.1.5.1 Italy: Radiation Oncology Market Breakdown, by Types
8.1.1.5.2 Italy: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
8.1.1.5.3 Italy: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
8.1.1.5.4 Italy: Radiation Oncology Market Breakdown, by Application
8.1.1.6 Rest of Europe: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8.1.1.6.1 Rest of Europe: Radiation Oncology Market Breakdown, by Types
8.1.1.6.2 Rest of Europe: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
8.1.1.6.3 Rest of Europe: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
8.1.1.6.4 Rest of Europe: Radiation Oncology Market Breakdown, by Application
9. Radiation Oncology Market - Industry Landscape
9.1 Overview
9.2 Growth Strategies in Radiation Oncology Market
9.3 Organic Growth Strategies
9.3.1 Overview
9.4 Inorganic Growth Strategies
9.4.1 Overview
10. Company Profiles
10.1 Varian Medical Systems Inc
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview (Siemens Healthineers AG)
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Elekta AB
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Accuray Incorporated
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 IBA Worldwide (Ion Beam Applications SA)
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Becton Dickinson and Co
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Products and Services
10.5.4 Financial Overview
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 Nordion
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Products and Services
10.6.4 Financial Overview
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 Mevion Medical Systems
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Products and Services
10.7.4 Financial Overview
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 NTP RADIOISOTOPES
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Products and Services
10.8.4 Financial Overview
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 Mallinckrodt Plc
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Products and Services
10.9.4 Financial Overview
10.9.5 SWOT Analysis
10.9.6 Key Developments
10.10 Curium
10.10.1 Key Facts
10.10.2 Business Description
10.10.3 Products and Services
10.10.4 Financial Overview
10.10.5 SWOT Analysis
10.10.6 Key Developments
11. Appendix
11.1 About The Insight Partners
11.2 Glossary of Terms
List of Tables
Table 1. Europe Radiation Oncology Market Segmentation
Table 2. Germany: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
Table 3. Germany: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
Table 4. Germany: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
Table 5. Germany: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 6. United Kingdom: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
Table 7. United Kingdom: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
Table 8. United Kingdom: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
Table 9. United Kingdom: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 10. France: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
Table 11. France: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
Table 12. France: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
Table 13. France: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 14. Spain: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
Table 15. Spain: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
Table 16. Spain: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
Table 17. Spain: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 18. Italy: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
Table 19. Italy: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
Table 20. Italy: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
Table 21. Italy: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 22. Rest of Europe: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
Table 23. Rest of Europe: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
Table 24. Rest of Europe: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
Table 25. Rest of Europe: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 26. Recent Organic Growth Strategies in Radiation Oncology Market
Table 27. Recent Inorganic Growth Strategies in the Radiation Oncology Market
Table 28. Glossary of Terms, Radiation Oncology Market
List of Figures
Figure 1. Europe Radiation Oncology Market Segmentation, by Country
Figure 2. Radiation Oncology Market - Key Market Dynamics
Figure 3. Statistics at Glance, Global, 2022
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Radiation Oncology Market Revenue (US$ Million), 2021-2031
Figure 6. Radiation Oncology Market Share (%) - by Types (2023 and 2031)
Figure 7. External Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Internal Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 9. Radiation Oncology Market Share (%) - by Application (2023 and 2031)
Figure 10. Breast Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 11. Prostate Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 12. Lung Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. Head and Neck Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 14. Cervical Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 15. Others: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Europe Radiation Oncology Market, by Key Countries - Revenue (2023) (US$ Million)
Figure 17. Europe: Radiation Oncology Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 18. Germany: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
Figure 19. United Kingdom: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
Figure 20. France: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
Figure 21. Spain: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
Figure 22. Italy: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
Figure 23. Rest of Europe: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
Figure 24. Growth Strategies in Radiation Oncology Market
- Varian Medical Systems Inc.
- Elekta AB.
- Accuray Incorporated.
- IBA Worldwide (Ion Beam Applications SA).
- Becton Dickinson and Co.
- Nordion.
- Mevion Medical Systems.
- NTP RADIOISOTOPES.
- Mallinckrodt Plc.
- Curium.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe radiation oncology market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Europe radiation oncology market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe radiation oncology market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.